Market Tracker

04/24 5:16pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

During the Trading Day
1.56 -0.02 / -1.27%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.56 0.00 / 0.00%
 
Volume: 14.7K

Today’s Trading

Previous close1.58
Today’s open1.58
Day’s range1.48 - 1.60
Volume1,829,095
Average volume (3 months)3,627,059
Market cap$394.3M
Dividend yield--
Data as of 3:59pm ET, 04/24/2014

Growth & Valuation

Earnings growth (last year)+7.32%
Earnings growth (this year)+24.74%
Earnings growth (next 5 years)--
Revenue growth (last year)+15.82%
P/E ratioNM
Price/Sales34.19
Price/Book2.12

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...+0.09+2.24%
OMEROmeros Corp+0.24+2.03%
ZGNXZogenix Inc+0.03+1.07%
PETXAratana Therapeutics...0.000.00%
Data as of 3:59pm ET, 04/24/2014

Financials

Next reporting dateMay 8, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$11.3M
Annual profit (last year)-$66.7M
Net profit margin-593.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts